生物工艺技术市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100001373
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 194
Buy Now

[研究报告]2022 年生物工艺技术市场规模为 308.9749 亿美元,预计到 2028 年将达到 770.9005 亿美元;预计 2023 年至 2028 年复合年增长率为 16.8%。

分析师观点

生物工艺的优势在于使用具有更低的压力、更低的温度和更有利的pH值,并且整个过程是可再生的。增加研发支出以引入新的药理化合物,并增加慢性病的患病率。严格的监管政策是生物工艺技术市场增长的最大影响因素。此外,先进生物工艺技术的引入为整个市场在预测期内呈指数增长提供了利润丰厚的市场机会。此外,自动化实时流式细胞仪 (ART-FCM) 的出现成为 2023-2028 年市场增长的未来趋势。根据报告中描述的细分,从细分类型来看,细胞培养基生物加工占比最大;同样,色谱生物工艺预计在预测期内(2023-2028 年)复合年增长率最高。此外,从形态来看,在预测期内,一次性使用部分将在生物加工技术中占据相当大的份额。在最终用户方面,生物制药公司的需求主要集中在生物制药公司。在预测期内,该细分市场将主导生物工艺技术市场的增长。

生物工艺技术是生物技术的重要组成部分,涉及将活物质或其成分结合在一起的过程。含有可生产特殊化学品、试剂和生物治疗药物的营养物质。与生物工艺技术相关的不同阶段包括底物和介质的制备、生物催化剂的选择和优化、批量生产、下游加工、纯化和最终加工。生物工艺技术应用广泛,从食品和药品到燃料和化学品。

战略展望

市场展望

增长研发支出用于引入新的药理化合物

制药公司正在研发上花费巨额资金,以针对各种治疗应用引入具有更大医疗和商业效力的新分子。 2019/2020财年,共有16家制药企业进入全球研发投入总额前50强。诺华、罗氏、强生强生、默克公司公司、葛兰素史克、辉瑞公司位列全球研发投入高额企业前10名。

主要药企研发投入

< /tr>

公司

2022年研发投入(百万美元)

2021年研发投入(百万美元)

吉利德科学公司

27,305

27,281

< /td>

百时美施贵宝公司

46,159

46,385

安进公司

< p>26,323

25,979

辉瑞

100,330

81,288

默克公司公司

59,283

48,704

< p>艾伯维公司

58,054

56,197

注:必要时考虑了货币兑换率。

资料来源:Insight Partners 公司年度报告和分析

< p> 

重磅炸弹分子的专利即将到期、管道中的潜在产品数量有限以及对生物制剂的需求不断增长,促使公司采用新技术,例如单次生物加工技术,以促进快速生产以及具有成本效益的产品交付流程。一次性系统和组件的制造商通常在洁净室中生产和组装产品,以确保它们不会将有害颗粒或内毒素引入生物过程。因此,在研发方面投入大量资金,以引入新的药理化合物并帮助生物加工技术的发展;这些技术支持新兴的生物制造能力以及原料、生物反应器和单元操作的相关互操作性。

基于类型的信息

根据类型,生物工艺技术市场细分为细胞培养基生物工艺、色谱生物工艺、消耗品和产品。配件及其他。细胞培养基生物工艺领域将在 2022 年占据最大的生物工艺技术市场份额,而色谱生物工艺预计在预测期内(2023-2028 年)将实现更高的复合年增长率。

< h3 >基于模态的信息

根据模态,全球生物工艺技术市场分为一次性和多次使用。到 2022 年,一次性细分市场将占据生物工艺技术更大的市场份额。预计多用途细分市场在预测期内将以更高的复合年增长率增长。

最终用户-基于信息

就最终用户而言,生物工艺技术市场分为学术市场和学术市场。医疗机构、生物制药公司、研究实验室等。 2022 年,生物制药公司市场份额最大,而学术和商业部门则最大。预计医疗机构在预测期内将实现更高的复合年增长率。

生物工艺技术市场,按类型:2022 年和 2028 年

< p>

区域分析

北美在生物工艺技术市场上占据主导地位,占据最大份额。该地区生物工艺技术市场的增长归因于推出创新产品(特别是与生物工艺技术相关)的大型企业的存在、该地区产品的不断引进以及生物工艺技术的技术进步。在北美,美国拥有最大的生物加工技术份额。根据美国食品和药物管理局 (FDA) 的报告,美国有超过 3000 万人患有大约 7000 种罕见疾病,这些疾病危及生命,治疗选择很少。由于缺乏对罕见疾病历史的了解以及进行临床试验的困难,用于治疗罕见疾病的药物、生物制剂和设备的开发具有挑战性。因此,细胞和基因疗法 (CGT) 以及特种药物等生物加工技术的发展代表了罕见疾病治疗的巨大变化。例如,与治疗罕见疾病的药物相比,CGT 具有显着的健康益处。在美国,超过 900 项针对基因治疗产品的研究性新药 (IND) 申请正在进行中。此外,FDA 每年批准 10 至 20 种基因疗法。同样,2022年8月,FDA批准了Bluebird Bio的“Zynteglo(betibeglogene autotemcel)”。这是美国批准用于治疗罕见神经系统疾病:脑性肾上腺脑白质营养不良 (CALD) 的最昂贵的单次药物。

德尔同样,亚太地区该地区将占据生物工艺技术市场最高的复合年增长率。在亚太地区,中国将在生物工艺技术市场占有相当大的市场份额。根据 BioPlan Associates 主要生物设施指数和生物制造商数据库报告,自过去 10 年以来,全球生物加工能力平均增长了 12%。中国在小分子和大分子药物市场上处于全球领先地位,分别排名全球第二和第三。此外,由于中国拥有合同开发和制造组织 (CDMO) 基地,中国是多家细胞和基因治疗开发商的所在地,这些组织约占该国生物产能的 25%。因此,中国拥有相当的生物制造能力,但严格遵守全球GMP标准,这增强了人们对生物制剂安全性和有效性的信心。

< tr>

国家/地区< /p>

生物制造设施(L)

< p>总体产能(%)

预计产能复合年增长率(%)

中国

177万

< /td>

10.2

15-20

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional market scenario of the bioprocess technology market?

Global bioprocess technology market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for bioprocess technology market. The US is expected to hold the largest share in the bioprocess technology market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia Pacific regional growth in the coming years.

Who are the key players in the bioprocess technology market?

Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics Ltd; are among the leading companies operating in the global bioprocess technology market

Which modality segment held the largest revenue (US$ Mn) in the bioprocess technology market?

The single use segment dominated the global bioprocess technology market.

Which product led the bioprocess technology market?

Based on type, cell culture media bioprocess took the forefront leaders in the worldwide market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.

What are the driving factors for the bioprocess technology market across the globe?

The growing R&D spendings to introduce new drug compounds, and increasing prevalence of chronic diseases. However, stringent regulatory policies are restricting the market growth.

What is meant by the bioprocess technology market?

Bioprocessing is the process that utilizes complete living cells or components (e.g., bacteria, enzymes, and proteins) to obtain desired products. The process is commonly known as fermentation. The entire process is divided into three stages: upstream process, fermentation, and downstream process. The upstream process involves preparation of liquid media, separation of particulate and inhibitory chemicals through sterilization and air purification. Additionally, fermentation involves the conversion of substrate to obtain desired products through biological agents such as microorganisms. Furthermore, downstream processing involves separation of cells from the fermentation broth, purification and concentration of desired products and waste disposal or recycle method.

The List of Companies - Bioprocess Technology Market

  1. Merck KGaA
  2. Sartorius AG
  3. Thermo Fisher Scientific Inc
  4. Corning Inc
  5. STAMM Biotech
  6. Lonza Group AG
  7. Eppendorf SE
  8. Repligen Corp
  9. Danaher Corp
  10. BioPharma Dynamics Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports